Komori
Kanmonkai (3372) · PolicyRestated

Policy of making food ingredient-related research and development the core of medium- to long-term growth

First written in FY2016. 28 of 30 entries say "Restated". Latest entry: FY2026-H1.

30entries
10years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY2018-Q3RestatedFY2019-Q1 – FY2026-H12016: 220162017: 420172018: 420182019: 220192020: 320202021: 320212022: 420222023: 420232024: 220242025: 22025
Same theme, other companies
Strengthening New Product and Technology Development Capabilities Through R&D and Basic ResearchA theme 216 companies write about · 0 as a headwind · 228 as a tailwind

47 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 190 companies compared. The sentences above are computed from all 190.Comparing 200 of the theme's 228 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026-H1RestatedAnnual report

    「Research and development expenditure for the interim consolidated accounting period was ¥1 million. There were no material changes in the Group's research and development activities during the period.」

    The company recorded ¥1 million in research and development expenditure and reaffirmed that there were no material changes in its research and development activities.
  2. FY2025RestatedAnnual report

    「The Group positions technology development related to ingredients, aimed at pursuing delicious, healthy and authentic taste, as a cornerstone supporting its medium- to long-term growth.」

    The company continues its policy of making ingredient-related technology a cornerstone of medium- to long-term growth and describes research and development involving the application of freezing and thawing technology to other ingredients, grilled fins and collagen. Research and development expenditure was ¥4 million.
  3. FY2025-H1RestatedAnnual report

    「Research and development expenditure for the interim consolidated accounting period was ¥2 million. There were no material changes in the Group's research and development activities during the period.」

    There were no material changes in the company's research and development activities, and research and development expenditure for the interim consolidated accounting period was ¥2 million.
  4. FY2024-Q3RestatedAnnual report

    「Research and development expenditure for the nine-month period ended [current third quarter] was ¥6 million. There were no material changes in the Group's research and development activities during the period.」

    Research and development expenditure was ¥6 million, and the company stated that there were no material changes in its research and development activities.
  5. FY2024-Q2RestatedAnnual report

    「Research and development expenditure for the six-month period ended [current second quarter] was ¥4 million. There were no material changes in the Group's research and development activities during the period.」

    The company reaffirmed that there were no material changes in its research and development activities and disclosed research and development expenditure of ¥4 million for the cumulative period.
  6. FY2024-Q1RestatedAnnual report

    「Research and development expenditure for the three-month period ended [current first quarter] was ¥1 million. There were no material changes in the Group's research and development activities during the period.」

    The company reaffirmed that there were no material changes in its research and development activities, and research and development expenditure for the quarter was ¥1 million.
  7. FY2023RestatedAnnual report

    「The company is conducting research into applying this technology to ingredients other than tiger pufferfish.」

    The company continues to develop technology for applying freezing, storage and thawing techniques to other ingredients, improving the growth and quality of tiger pufferfish, and producing grilled fins and collagen. Research and development expenditure was ¥11 million.
  8. FY2023-Q3RestatedAnnual report

    「Research and development expenditure for the nine-month period ended [current third quarter] was ¥7 million. There were no material changes in the Group's research and development activities during the period.」

    Research and development expenditure was ¥7 million, and the company stated that there were no material changes in its research and development activities.
  9. FY2023-Q2RestatedAnnual report

    「Research and development expenditure for the six-month period ended [current second quarter] was ¥4 million. There were no material changes in the Group's research and development activities during the period.」

    The company recorded ¥4 million in research and development expenditure and reaffirmed that there were no material changes in its research and development activities.
  10. FY2023-Q1RestatedAnnual report

    「Research and development expenditure for the three-month period ended [current first quarter] was ¥2 million. There were no material changes in the Group's research and development activities during the period.」

    The company recorded ¥2 million in research and development expenditure and reaffirmed that there were no material changes in its research and development activities.
  11. FY2022RestatedAnnual report

    「The company positions technology development related to ingredients, aimed at pursuing delicious, healthy and authentic taste, as a cornerstone supporting its medium- to long-term growth.」

    The company reaffirmed its research and development policy of making ingredient-related technology a cornerstone of medium- to long-term growth. Research and development expenditure was ¥25 million.
  12. FY2022-Q3RestatedAnnual report

    「Research and development expenditure for the nine-month period ended [current third quarter] was ¥24 million. There were no material changes in the Group's research and development activities during the period.」

    The company recorded ¥24 million in research and development expenditure and reaffirmed that there were no material changes in its research and development activities.
  13. FY2022-Q2RestatedAnnual report

    「Research and development expenditure for the six-month period ended [current second quarter] was ¥15 million. There were no material changes in the Group's research and development activities during the period.」

    The company recorded ¥15 million in research and development expenditure and stated that there were no material changes in its research and development activities.
  14. FY2022-Q1RestatedAnnual report

    「Research and development expenditure for the three-month period ended [current first quarter] was ¥5 million. There were no material changes in the Group's research and development activities during the period.」

    The company recorded ¥5 million in research and development expenditure and stated that there were no material changes in its research and development activities.
  15. FY2021RestatedAnnual report

    「The company positions technology development related to ingredients, aimed at pursuing delicious, healthy and authentic taste, as a cornerstone supporting its medium- to long-term growth.」

    The company continues to pursue a research and development policy centered on ingredient-related technology as a cornerstone of medium- to long-term growth. Research and development expenditure was ¥25 million.
  16. FY2021-Q2RestatedAnnual report

    「Research and development expenditure for the six-month period ended [current second quarter] was ¥6 million. There were no material changes in the Group's research and development activities during the period.」

    The company recorded ¥6 million in research and development expenditure and reaffirmed that there were no material changes in its research and development activities.
  17. FY2020RestatedAnnual report

    「The company positions technology development related to ingredients, aimed at pursuing delicious, healthy and authentic taste, as a cornerstone supporting its medium- to long-term growth.」

    The company continues to position ingredient-related technology as a cornerstone of medium- to long-term growth. Research and development expenditure was ¥27 million.
  18. FY2020-Q3RestatedAnnual report

    「Research and development expenditure for the nine-month period ended [current third quarter] was ¥22 million. There were no material changes in the Group's research and development activities during the period.」

    The company recorded ¥22 million in research and development expenditure and reaffirmed that there were no material changes in its research and development activities.
  19. FY2020-Q1RestatedAnnual report

    「Research and development expenditure for the three-month period ended [current first quarter] was ¥6 million. There were no material changes in the Group's research and development activities during the period.」

    The company explicitly stated that there were no material changes in its research and development activities and recorded ¥6 million in research and development expenditure.
  20. FY2019-Q3RestatedAnnual report

    「Research and development expenditure for the nine-month period ended [current third quarter] was ¥19 million. There were no material changes in the Group's research and development activities during the period.」

    The company recorded ¥19 million in research and development expenditure and stated that there were no material changes in its research and development activities.
  21. FY2019-Q2RestatedAnnual report

    「Research and development expenditure for the six-month period ended [current second quarter] was ¥13 million. There were no material changes in the Group's research and development activities during the period.」

    The company recorded ¥13 million in research and development expenditure and stated that there were no material changes in its research and development activities.
  22. FY2019-Q1RestatedAnnual report

    「The Group's total research and development expenditure during the cumulative first quarter was ¥7 million. There were no significant changes to the Group's research and development activities during the cumulative first quarter.」

    The company reported R&D expenses of ¥7 million and no significant changes to its research and development activities.
  23. FY2018AdvancedAnnual report

    「The large torafugu produced through the company's partnership and technical cooperation with torafugu aquaculture operators began being sold at the company's stores during the consolidated fiscal year. The company is also conducting research to improve torafugu growth and quality.」

    Large torafugu produced through cooperation and technical collaboration with aquaculture operators began being sold at the company's stores during the consolidated fiscal year, and research to improve growth and quality is continuing. R&D expenses were ¥29 million.
  24. FY2018-Q3RestatedAnnual report

    「The Group's total research and development expenditure during the cumulative third quarter was ¥20 million. There were no significant changes to the Group's research and development activities during the cumulative third quarter.」

    The company reported R&D expenses of ¥20 million and no significant changes to its research and development activities.
  25. FY2018-Q2RestatedAnnual report

    「Research and development expenditure during the cumulative second quarter was ¥17 million. There were no significant changes to the company's research and development activities during the cumulative second quarter.」

    The company reported R&D expenses of ¥17 million and no significant changes to its research and development activities.
  26. FY2018-Q1RestatedAnnual report

    「Research and development expenditure during the cumulative first quarter was ¥9 million. There were no significant changes to the company's research and development activities during the cumulative first quarter.」

    The company reported R&D expenses of ¥9 million and no significant changes to its research and development activities.
  27. FY2017RestatedAnnual report

    「The company has defined technological development related to food ingredients, aimed at pursuing delicious, healthy, authentic taste, as the foundation supporting its medium- to long-term growth, and has actively invested in research and development since establishing its R&D department in October 1999.」

    The company positions food-ingredient technology as the foundation of medium- to long-term growth and continues to invest in research and development. R&D expenses were ¥34 million.
  28. FY2017-Q3RestatedAnnual report

    「The Group's total research and development expenditure during the cumulative third quarter was ¥25 million. There were no significant changes to the Group's research and development activities during the cumulative third quarter.」

    The company reported R&D expenses of ¥25 million and no significant changes to its research and development activities.
  29. FY2017-Q1RestatedAnnual report

    「The Group's total research and development expenditure during the cumulative first quarter was ¥9 million. There were no significant changes to the Group's research and development activities during the cumulative first quarter.」

    Explicitly stating that there were no material changes in research and development activities.
  30. FY2016First statedAnnual report

    「The Group has defined technological development related to food ingredients, aimed at pursuing delicious, healthy, authentic taste, as the foundation supporting its medium- to long-term growth, and has actively invested in research and development since establishing its R&D department in October 1999.」

    The company positions food-ingredient technology as the foundation of medium- to long-term growth and continues to invest in research and development. R&D expenses were ¥25 million.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Kanmonkai yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Policy of making food ingredient-related research and development the core of medium- to long-term growth | KANMONKAI Co.,Ltd. (3372) | Komori